PHARMACYTE BIOTECH INC (PMCB)
US71715X2036 - Common Stock
| TTM (2024-1-31) | 2023 (2023-4-30) | 2022 (2022-4-30) | 2021 (2021-4-30) | 2020 (2020-4-30) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Cost Of Goods | N/A | N/A | N/A | N/A | N/A | |||
| Gross Profit | N/A | N/A | N/A | N/A | N/A | |||
| Operating Expenses | 6.26M | 6.46M | 4.39M | 3.63M | 3.83M | |||
| Research and Development | 398.76K | 470.00K | 690.00K | 920.00K | 300.00K | |||
| Selling, General, and Administrative Expenses | 5.86M | 5.99M | 3.70M | 2.71M | 3.53M | |||
| Operating Income | -6.26M | -6.46M | -4.39M | -3.63M | -3.83M | |||
| Interest Income/Expense | 3.51M | 1.94M | 160.00K | 0.00 | 0.00 | |||
| Other Income/Expense | 1.60M | 200.00K | 0.00 | 0.00 | 0.00 | |||
| Non Recurring Items | N/A | N/A | 0.00 | 80.00K | N/A | |||
| Income Before Taxes | -1.14M | -4.32M | -4.24M | -3.55M | -3.83M | |||
| Income Tax | N/A | N/A | N/A | N/A | N/A | |||
| Net Income | -11.51M | -4.32M | -4.24M | -3.55M | -3.83M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -1.32 | -0.22 | -0.27 | -2.45 | -4.21 | |||
| Statistics | ||||||||
All data in USD